RP
Rajesh Prasad Shrivastava
About Rajesh Prasad Shrivastava
Data last updated:
Rajesh Prasad Shrivastava has 28 years in corporate governance. Formerly with 6 companies, such as Ayush Bio - Tech Private Limited and Iatro Pharma And Biotech Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ayush Bio - Tech Private Limited U74900UP2008PTC034454 | Director | 26 Feb 2010 | 2008 | – | Strike Off |
| Iatro Pharma And Biotech Limited U24232PN2005PLC021025 | Director | 04 Jan 2010 | 2005 | – | Active |
| Medexport (India) Limited L51909DL1997PLC087111 | Director | 01 Apr 1998 | 1997 | – | Active |
| Neozen Lifecare Private Limited U74999DL2017PTC320160 | Director | 04 Jul 2017 | 2017 | – | Strike Off |
| Iceglory Communications Private Limited U24100DL2007PTC170725 | Additional Director | 01 Oct 2020 | 2007 | ₹3.1 Lakh (FY 2017) | Active |
| Francis Remedies (India) Private Limited U24231DL2006PTC146931 | Director | 03 May 2021 | 2006 | ₹12.19 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Prasad Shrivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Prasad Shrivastava
Rajesh Prasad Shrivastava has 28 years in corporate governance. Formerly with 6 companies, such as Ayush Bio - Tech Private Limited and Iatro Pharma And Biotech Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Rajesh Prasad Shrivastava has expertise in Technology, General Business.
Rajesh Prasad Shrivastava has 28 years in corporate governance.